Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

The US Food and Drug Administration (FDA) has unveiled a new programme that will reduce its review time for certain drug ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...